221 related articles for article (PubMed ID: 30596651)
1. Toll-like receptor 2 confers partial neuroprotection during prion disease.
Carroll JA; Race B; Williams K; Chesebro B
PLoS One; 2018; 13(12):e0208559. PubMed ID: 30596651
[TBL] [Abstract][Full Text] [Related]
2. Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.
Carroll JA; Striebel JF; Race B; Phillips K; Chesebro B
J Virol; 2015 Feb; 89(4):2388-404. PubMed ID: 25505076
[TBL] [Abstract][Full Text] [Related]
3. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10.
Mödinger Y; Rapp A; Pazmandi J; Vikman A; Holzmann K; Haffner-Luntzer M; Huber-Lang M; Ignatius A
J Cell Mol Med; 2018 Dec; 22(12):6002-6014. PubMed ID: 30247799
[TBL] [Abstract][Full Text] [Related]
4. CD11c is not required by microglia to convey neuroprotection after prion infection.
Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
[TBL] [Abstract][Full Text] [Related]
5. Complement facilitates early prion pathogenesis.
Klein MA; Kaeser PS; Schwarz P; Weyd H; Xenarios I; Zinkernagel RM; Carroll MC; Verbeek JS; Botto M; Walport MJ; Molina H; Kalinke U; Acha-Orbea H; Aguzzi A
Nat Med; 2001 Apr; 7(4):488-92. PubMed ID: 11283678
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
7. Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie.
García-Martínez M; Cortez LM; Otero A; Betancor M; Serrano-Pérez B; Bolea R; Badiola JJ; Garza MC
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408945
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state.
Saba R; Gushue S; Huzarewich RL; Manguiat K; Medina S; Robertson C; Booth SA
PLoS One; 2012; 7(2):e30832. PubMed ID: 22363497
[TBL] [Abstract][Full Text] [Related]
9. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
11. Microglia Are Critical in Host Defense against Prion Disease.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
[TBL] [Abstract][Full Text] [Related]
12. RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint.
Strainic MG; Pohlmann E; Valley CC; Sammeta A; Hussain W; Lidke DS; Medof ME
FASEB J; 2020 Feb; 34(2):2105-2125. PubMed ID: 31908021
[TBL] [Abstract][Full Text] [Related]
13. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).
Pogue AI; Lukiw WJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502105
[TBL] [Abstract][Full Text] [Related]
14. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
[TBL] [Abstract][Full Text] [Related]
15. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
16. Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35.
Tribouillard-Tanvier D; Race B; Striebel JF; Carroll JA; Phillips K; Chesebro B
J Virol; 2012 Oct; 86(19):10377-83. PubMed ID: 22787236
[TBL] [Abstract][Full Text] [Related]
17. Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia.
Zolini GP; Lima GK; Lucinda N; Silva MA; Dias MF; Pessoa NL; Coura BP; Cartelle CT; Arantes RM; Kroon EG; Campos MA
J Neuroinflammation; 2014 Jan; 11():20. PubMed ID: 24479442
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
[TBL] [Abstract][Full Text] [Related]
19. TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.
Chattoraj P; Yang Q; Khandai A; Al-Hendy O; Ismail N
PLoS One; 2013; 8(3):e58514. PubMed ID: 23526993
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2-independent and MyD88-dependent gene expression in the mouse brain.
Naert G; Laflamme N; Rivest S
J Innate Immun; 2009; 1(5):480-93. PubMed ID: 20375605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
